Boston-based research device developer 908 Devices completed its $125 million initial public offering, and its shares are now available to trade on the Nasdaq under the ticker "MASS." Shares are available for limit orders via Robinhood.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $3.63 |
|---|---|
| 52-week range | $3.91 - $12.51 |
| 50-day moving average | $4.86 |
| 200-day moving average | $6.48 |
| Wall St. target price | $15.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-1.15 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.63 from 2024-09-05
| 1 week (2024-08-30) | -8.10% |
|---|---|
| 1 month (2024-08-07) | -17.50% |
| 3 months (2024-06-07) | -41.17% |
| 6 months (2024-03-07) | -47.69% |
| 1 year (2023-09-07) | -46.46% |
|---|---|
| 2 years (2022-09-07) | -81.23% |
| 3 years (2021-09-07) | 39.07 |
| 5 years (2019-09-03) | N/A |
| Revenue TTM | $52.7 million |
|---|---|
| Gross profit TTM | $26 million |
| Return on assets TTM | -13.49% |
| Return on equity TTM | -22.96% |
| Profit margin | -72.1% |
| Book value | $4.52 |
| Market Capitalization | $136.9 million |
TTM: trailing 12 months
We're not expecting 908 Devices to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, 908 Devices's shares have ranged in value from as little as $3.91 up to $12.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 908 Devices's is 0.978. This would suggest that 908 Devices's shares are less volatile than average (for this exchange).
To put 908 Devices's beta into context you can compare it against those of similar companies.
908 Devices Inc. , a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Use this calculator to quickly see potential outcomes of your options trades.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.